期刊文献+

探讨炎症性肠病中凝血异常与炎性反应的关系 被引量:1

下载PDF
导出
摘要 目的:确定炎症性肠病中出现的凝血异常现象与炎性反应之间是否存在某种关系。方法:随机选取60例炎症性肠病病例作为试验组,另随机选取60例健康自愿者作为对照组,通过检测患者在炎症发生和静止期,以及炎症患者与健康人之间凝血因子Ⅷ、血小板数量、血小板体积、凝血酶原片段等的变化,探讨炎症性肠病发生时凝血异常与炎性反应之间的关系。结果:患者在发生炎性反应期间和静止期间、患者在发生炎性反应时与健康人之间上述各类因子比较差异均有统计学意义(P<0.05)。结论:炎症性肠病中发生炎性反应会影响各类凝血因子的分泌及作用,说明炎性反应与炎症性肠病凝血异常呈正向关系。
作者 杨纪国
出处 《中外医学研究》 2013年第21期150-151,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献3

二级参考文献20

  • 1LARSEN TB, NIELSEN JN, FREDHOLM L. Platelets and anticoagulant capacity in patients with inflammatroy bowel disease [ J ]. Pathophysiol Haemost Thromb,2002,32 ( 2 ) :92.
  • 2KAPSORITAKIS AN, KOUKOURAKIS MI, SFIRIDAKI A, et al. Mean Platelet volume:a useful marker of inflammatory bowel disease activity[J]. Am J Gastroenterol,2001,96(3) :776.
  • 3CARTY E, MACEY M, RAMPTON DS. Inhibition of platelet activity by 5-aminosalicylic acid in inflammatory bowel disease [ J ]. Aliment Pharmacol Ther,2000,14 (9) : 1169.
  • 4TYTGAT GN, VAN NUETEN L, VAN DE VELED, et al. Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis two muticentre, randomized, double-blind studies [ J ]. Aliment Phamacol Ther,2002,16 ( 1 ) :87.
  • 5CARTER M J, LOBO AJ, TRAVIS SP. IBD section, British society of gastroenterology. Guidelines for the management of inflammatory bowel disease in adults[J]. Gut,2004,53(5) :1.
  • 6SIMONIS B, HEINE M, HEENE DL, et al. Evaluation and validation of Crohn' s disease inflammatory activity index reflecting patterm of endoscopic severity [ J ]. Scand J Gastroenterol, 1998,33 ( 3 ) :283.
  • 7SOLEM CA, LOFTUS EV Jr,Tremaine WJ,et al. Correlation of C-reactive protein with clinical endoscopic histologic and radiographic activity in inflammatory bowel disease[ J]. Infamn Bowel Dis,2005,11 (8) :707.
  • 8Bernstin CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost, 2001,85 : 430-434.
  • 9Quera R, Shanahan F. Thromboembotism-an important manifestation of inflammatory bowel disease. Am J Gastroenterol, 2004,99 : 1971-1973.
  • 10Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and frbrinolysis. Pathophysiol Haemost Thromb, 2003 2004, 33:375-381.

共引文献19

同被引文献13

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部